(2020). Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5065
. K. Rengerink
First name
K.
Middle name
O.
Last name
Rengerink